Compagnie Lombard Odier S Cm A Pacific Biosciences Of California, Inc. Transaction History

Compagnie Lombard Odier S Cm A

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$19.26 - $30.08 $0 - $0	0 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$24.86 - $35.02 $310,750 - $437,750	-12,500 Closed	0 $0
Q2 2021 Jul 15, 2021	BUY	$22.3 - $36.02 $234,150 - $378,210	10,500 Added 525.0%	12,500 $437,000
Q1 2021 Apr 23, 2021	BUY	$26.38 - $51.15 $52,760 - $102,300	2,000 New	2,000 $67,000
Q4 2020 Feb 09, 2021	BUY	$10.5 - $28.5 $0 - $0	0 New	0 $0
Q3 2019 Nov 12, 2019	SELL	$4.99 - $6.16 $49,900 - $61,600	-10,000 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$3.99 - $7.82 $458,850 - $899,300	-115,000 Reduced 92.0%	10,000 $74,000
Q3 2018 Nov 13, 2018	SELL	$3.52 - $5.55 $105,600 - $166,500	-30,000 Reduced 19.35%	125,000 $676,000
Q2 2018 Aug 10, 2018	SELL	$2.11 - $3.92 $52,750 - $98,000	-25,000 Reduced 13.89%	155,000 $552,000
Q1 2018 May 11, 2018	BUY	$2.05 - $3.23 $61,499 - $96,900	30,000 Added 20.0%	180,000 $366,000
Q3 2017 Nov 14, 2017	BUY	$3.2 - $5.57 $9,600 - $16,710	3,000 Added 2.04%	150,000 $786,000
Q2 2017 Aug 14, 2017	BUY	N/A	147,000	147,000 $524,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.